What We Do

RetVas provides a state of the art retinal image analysis service that is fully automated.

The techniques the software uses for analysis are based on human visual cortex processing (how the human brain sees). This service is the first of its kind, and its aim is to provide an accurate screening tool for retinopathy of prematurity, diabetic retinopathy and cardiovascular wellness.

20% of RetVas profits go towards the incorporation of the software in communities where premature infants are currently going blind for lack of screening methods.